Success Metrics

Clinical Success Rate
90.0%

Based on 9 completed trials

Completion Rate
90%(9/10)
Active Trials
2(10%)
Results Posted
11%(1 trials)
Terminated
1(5%)

Phase Distribution

Ph phase_4
7
35%
Ph not_applicable
6
30%

Phase Distribution

0

Early Stage

0

Mid Stage

7

Late Stage

Phase Distribution13 total trials
Phase 4Post-market surveillance
7(53.8%)
N/ANon-phased studies
6(46.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

2

trials recruiting

Total Trials

20

all time

Status Distribution
Active(4)
Completed(9)
Terminated(2)
Other(5)

Detailed Status

Completed9
unknown5
Terminated1
Withdrawn1
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
2
Success Rate
90.0%
Most Advanced
Phase 4

Trials by Phase

Phase 47 (53.8%)
N/A6 (46.2%)

Trials by Status

unknown525%
completed945%
terminated15%
withdrawn15%
not_yet_recruiting15%
recruiting15%
active_not_recruiting15%
enrolling_by_invitation15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT07100483Not Applicable

Comparing Surgical Management Methods of Atrial Fibrillation

Enrolling By Invitation
NCT07159685

Sex-Based Differences of LA: Impact on AF Ablation.

Not Yet Recruiting
NCT00964392Phase 4

NAVISTAR® THERMOCOOL® Catheter Post Approval Registry

Completed
NCT06207383Not Applicable

Atrial Fibrillation Ablation Versus Atrioventricular Nodal Ablation with Conduction System Pacing in Heart Failure

Recruiting
NCT06620575

Evaluation of Predictive Factors for Recurrence of Persistent Atrial Fibrillation After Ablation

Completed
NCT06497933

Exhaustive French National Registry of AF Ablation Using Pentaspline Pulsed Field Ablation Catheter

Active Not Recruiting
NCT03737838

Propagation ANalysis for Arrhythmogenic Conduction Elimination to Prevent Atrial Flutter and Fibrillation (PANACEA-AF)

Completed
NCT04649801Not Applicable

Catheter Ablation for Atrial Fibrillation in patientS With End-sTage Heart Failure and Eligibility for Heart Transplantation

Completed
NCT05781282Phase 4

Pulmonary Vein (PV) Imaging by Intracardiac Echography (ICE) After Ablation

Unknown
NCT04055961

Atrial Fibrillation Ablation Registry

Unknown
NCT05319769

Non Fluoroscopic APpROach iN atriaL Fibrillation Ablation procEdureS

Completed
NCT04832646

VOLTage Mapping in Atrial Fibrillation

Unknown
NCT03564951Not Applicable

Ablation of Anisochronous Zones vs Spatio-temporal Dispersal Zones With Antral Electrical Isolation During Radiofrequency Treatment of Paroxysmal or Persistent Atrial Fibrillation

Completed
NCT02917044Not Applicable

Use of a High Density Mapping System to Complete Wide Area Circumferential Ablation of the Pulmonary Veins and Avoid Ostial Segmental Ablation

Terminated
NCT00729911Phase 4

Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD

Completed
NCT02294929Not Applicable

Cryoballoon Ablation in Patients With Longstanding Persistent Atrial Fibrillation

Unknown
NCT02243891Phase 4

AF Ablation With or Without ROX Coupler Study

Unknown
NCT02120560Phase 4

Anticoagulation in AF Ablation and Effects on Neurocognitive Function

Withdrawn
NCT01038115Phase 4

Study Comparing Pulmonary Vein Isolation With the Cryoballoon, Radiofrequency Energy, or Both in the Treatment of Atrial Fibrillation (AF)

Completed
NCT00863213Phase 4

Study of Ablation Versus antiaRrhythmic Drugs in Persistent Atrial Fibrillation

Completed

All 20 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
20